🔴 Damora Therapeutics is trading 5.6% down today with no clear company-specific catalyst

Damora Therapeutics is trading 5.55% down at $26.82, but no clear company-specific announcement explains the September 15, 2026 decline.

• The latest identifiable company disclosure was a September 3 inducement-grant announcement.
• September 15 coverage discussed the pipeline rather than a new catalyst.
• Broader sentiment is cautious ahead of the Federal Reserve decision, though healthcare is outperforming overall; the cause remains uncertain rather than clearly sector-driven.